β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis

Objectives Pathologic fibroblast activation drives fibrosis of the skin and internal organs in patients with systemic sclerosis (SSc). β-catenin is an integral part of adherens junctions and a central component of canonical Wnt signaling. Here, the authors addressed the role of β-catenin in fibroblasts for the development of SSc dermal fibrosis. Methods Nuclear accumulation of β-catenin in fibroblasts was assessed by triple staining for β-catenin, prolyl-4-hydroxylase-β and 4′,6-diamidino-2-phenylindole (DAPI). The expression of Wnt proteins in the skin was analysed by real-time PCR and immunohistochemistry. Mice with fibroblast-specific stabilisation or fibroblast-specific depletion were used to evaluate the role of β-catenin in fibrosis. Results The auhors found significantly increased nuclear levels of β-catenin in fibroblasts in SSc skin compared to fibroblasts in the skin of healthy individuals. The accumulation of β-catenin resulted from increased expression of Wnt-1 and Wnt-10b in SSc. The authors further showed that the nuclear accumulation of β-catenin has direct implications for the development of fibrosis: Mice with fibroblast-specific stabilisation of β-catenin rapidly developed fibrosis within 2 weeks with dermal thickening, accumulation of collagen and differentiation of resting fibroblasts into myofibroblasts. By contrast, fibroblast-specific deletion of β-catenin significantly reduced bleomycin-induced dermal fibrosis. Conclusions The present study findings identify β-catenin as a key player of fibroblast activation and tissue fibrosis in SSc. Although further translational studies are necessary to test the efficacy and tolerability of β-catenin/Wnt inhibition in SSc, the present findings may have clinical implications, because selective inhibitors of β-catenin/Wnt signaling have recently entered clinical trials.

[1]  G. Mutlu,et al.  Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. , 2011, American journal of respiratory cell and molecular biology.

[2]  J. Zwerina,et al.  Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway , 2011, Annals of the rheumatic diseases.

[3]  O. MacDougald,et al.  Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? , 2011, Arthritis and rheumatism.

[4]  N. Alenina,et al.  Platelet-derived serotonin links vascular disease and tissue fibrosis , 2011, The Journal of experimental medicine.

[5]  M. Mattson,et al.  Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. , 2011, Arthritis and rheumatism.

[6]  M. Yaniv,et al.  The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis , 2011, Annals of the rheumatic diseases.

[7]  E. Prochownik,et al.  Point Mutations in c-Myc Uncouple Neoplastic Transformation from Multiple Other Phenotypes in Rat Fibroblasts , 2010, PloS one.

[8]  Elisabetta Dejana,et al.  The Role of Wnt Signaling in Physiological and Pathological Angiogenesis , 2010, Circulation research.

[9]  G. Schett,et al.  Animal models of systemic sclerosis: prospects and limitations. , 2010, Arthritis and rheumatism.

[10]  C. Nguyên,et al.  Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis , 2010, Proceedings of the National Academy of Sciences.

[11]  R. Nusse,et al.  Towards an integrated view of Wnt signaling in development , 2009, Development.

[12]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[13]  Youhua Liu,et al.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis. , 2009, Journal of the American Society of Nephrology : JASN.

[14]  J. David,et al.  The role of Wnt proteins in arthritis , 2008, Nature Clinical Practice Rheumatology.

[15]  Walter Birchmeier,et al.  Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. , 2008, Genes & development.

[16]  W. Seeger,et al.  Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis , 2008, PloS one.

[17]  Xi He,et al.  Wnt/beta-catenin signaling: new (and old) players and new insights. , 2008, Current opinion in cell biology.

[18]  R. Kumar,et al.  Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis. , 2008, The Journal of investigative dermatology.

[19]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[20]  E. Chakravarty,et al.  Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. , 2007, Rheumatology.

[21]  Andrea Giustina,et al.  Mechanisms of anabolic therapies for osteoporosis. , 2007, The New England journal of medicine.

[22]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[23]  Hans Clevers,et al.  β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[25]  K. Surendran,et al.  A role for Wnt-4 in renal fibrosis. , 2002, American journal of physiology. Renal physiology.

[26]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[27]  M. Taketo,et al.  Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene , 1999, The EMBO journal.

[28]  J. F. Woessner,et al.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.

[29]  A. E. Wakil TOWARDS AN INTEGRATED VIEW OF Wnt SIGNALING IN MOUSE ADRENOCORTICAL FUNCTIONAL ZONATION , 2012 .

[30]  G. Zaman,et al.  New avenues to target Wnt/β-catenin signaling. , 2011, Drug discovery today.

[31]  R. Behringer,et al.  Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. , 2007, Arthritis and rheumatism.

[32]  Oliver Distler,et al.  Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. , 2007, Arthritis and rheumatism.

[33]  Madoka Sato Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. , 2006, Acta dermato-venereologica.

[34]  V. Poletti,et al.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. , 2003, The American journal of pathology.

[35]  V. Poletti,et al.  Aberrant Wnt/ (cid:1) -Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis , 2003 .